Why Agilon Health Inc (AGL) Stock Is Rising
As of 2026-11-12, Agilon Health Inc (AGL) has a next-year EPS growth estimate of 2366.39%. Featured in 7 EPS revision reports, most recently on 2026-05-20.
Why AGL Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised Agilon Health Inc's next-year EPS growth estimate from 174.27% to 333.49% on 2026-11-05.
- +Sustained Upward Momentum: The estimate has risen consistently across 4 trading sessions since detection, now up a net +2032.90 pp to 2366.39%.
- !Largest Single-Day Revision: +1610.68 pp on 2026-11-12 (755.71% → 2366.39%).
- ·Current-Year Growth: Projected at 99.46%, supporting the forward estimate revision.
News Context
AGL has been rising primarily because next-year EPS growth estimates were sharply upgraded, from 174.27% to 333.49% on 2026-11-05. The move plausibly connects to Q3 2026 results, where Agilon swung to a $1.97 profit and lifted its EBITDA guidance again, though one-time catch-ups and a softer 2027 tailwind tempered the beat. The estimate has continued rising across three trading sessions, reaching a current next-year EPS growth estimate of 755.71%.
Generated 2026-11-12 · news as of 2026-11-12
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- EPS growth next year
- 2366.39%
- EPS growth this year
- 99.46%
- EPS next quarter (est)
- -$3.38
- Last price
- $110.09
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-12 | 2366.39% | 99.46% | -$3.38 | $110.09 |
| 2026-11-11 | 755.71% | 98.20% | -$3.39 | $114.81 |
| 2026-11-10 | 487.54% | 97.05% | -$3.37 | $113.52 |
| 2026-11-09 | 479.00% | 97.06% | -$3.40 | $114.02 |
| 2026-11-07 | 479.00% | 97.06% | -$3.40 | $113.39 |
| 2026-11-06 | 479.00% | 97.06% | -$3.40 | $113.39 |
| 2026-11-05 | 333.49% | 95.66% | -$3.42 | $113.77 |
| 2026-11-04 | 174.27% | 90.51% | -$1.23 | $96.23 |
| 2026-11-03 | 174.27% | 90.51% | -$1.23 | $87.79 |
| 2026-11-02 | 174.27% | 90.51% | -$1.23 | $86.63 |
| 2026-10-31 | 174.27% | 90.51% | -$1.23 | $84.90 |
| 2026-10-30 | 174.27% | 90.51% | -$1.23 | $84.90 |
| 2026-10-29 | 174.27% | 90.51% | -$1.23 | $85.94 |
| 2026-10-28 | 174.27% | 90.51% | -$1.23 | $91.00 |
| 2026-10-27 | 174.27% | 90.51% | -$1.23 | $90.65 |
| 2026-10-26 | 174.27% | 90.51% | -$1.23 | $90.34 |
| 2026-10-23 | 174.27% | 90.51% | -$1.23 | $89.71 |
| 2026-10-22 | 174.27% | 90.51% | -$1.23 | $90.29 |
| 2026-10-21 | 174.27% | 90.51% | -$1.23 | $90.99 |
| 2026-10-20 | 174.27% | 90.51% | -$1.23 | $91.72 |
| 2026-10-19 | 174.27% | 90.51% | -$1.23 | $88.83 |
| 2026-10-16 | 174.27% | 90.51% | -$1.23 | $85.12 |
| 2026-10-15 | 174.27% | 90.51% | -$1.23 | $88.45 |
| 2026-10-14 | 174.27% | 90.51% | -$1.23 | $87.40 |
| 2026-10-13 | 174.27% | 90.51% | -$1.23 | $85.90 |
| 2026-10-12 | 174.27% | 90.51% | -$1.23 | $85.49 |
| 2026-10-11 | 174.27% | 90.51% | -$1.23 | $82.39 |
| 2026-10-10 | 174.27% | 90.51% | -$1.23 | $82.39 |
| 2026-10-09 | 174.27% | 90.51% | -$1.23 | $82.39 |
| 2026-10-08 | 174.27% | 90.51% | -$1.23 | $84.72 |
Reports Featuring AGL
- 2026-05-20
AMPG, GCTS Lead EPS Revision Winners With 33-54% Gains This Week
- 2026-05-19
Healthcare Stocks Surge as LQDA, ERNA Lead EPS-Driven Rally
- 2026-05-18
Why ERNA, RDW, BRUN Led Gains After EPS Estimate Revisions
- 2026-05-14
AGL Jumps 194% as Healthcare Revisions Drive Top Performers
- 2026-05-13
AGL Rockets 169% as Healthcare Revisions Sweep Top Movers
- 2026-05-12
AGL Surges 160% After Earnings Beat; AMD, RIOT Lead Tech Rally
- 2026-05-11
Agilon Surges 123%: How EPS Revisions Triggered Mega-Cap Rally
Recent News
- agilon health to Host Virtual Investor Event Driving Performance At Scale: The agilon Framework on November 17, 2026Business Wire
- agilon health to Host Virtual Investor Event Driving Performance At Scale: The agilon Framework on November 17, 2026Business Wire
- Agilon Health Swings To A $1.97 Profit And Lifts EBITDA Guide Again, But One-Time Catch-Ups And A Softer 2027 Tailwind Temper The BeatEarnings Whispers
- Agilon Health Swings To A $1.97 Profit And Lifts EBITDA Guide Again, But One-Time Catch-Ups And A Softer 2027 Tailwind Temper The BeatEarnings Whispers
- Agilon: Q3 Earnings SnapshotAssociated Press
- Agilon: Q3 Earnings SnapshotAssociated Press
- agilon health Reports Third Quarter 2026 ResultsBusiness Wire
- Agilon Faces Its Breakeven Quarter: Will Cost Trends Beat A Deliberately Cautious Guide?Earnings Whispers
- agilon health to Participate in Upcoming ConferencesBusiness Wire
- Agilon: Q2 Earnings SnapshotAssociated Press
Screen Performance
Aggregate stats across all 2145 tickers our top-EPS-revision screen has flagged over the past 225 days.
- Median return since detection
- -2.9%
- % of tickers in the green
- 43%
- Median return on winners
- +22.8%
- Large revisions captured
- 2246
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Agilon Health Inc (AGL) stock go up recently?▾
Agilon Health Inc (AGL) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 174.27% to 333.49% on 2026-11-05. The estimate has since risen consistently across 4 additional trading sessions, gaining a net +2032.90 pp to 2366.39%. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Agilon Health Inc's next-year EPS growth estimate?▾
As of 2026-11-12, Agilon Health Inc (AGL) has a next-year EPS growth estimate of 2366.39%, based on analyst consensus.
When was the latest EPS estimate revision for AGL?▾
The most recent revision occurred on 2026-11-12, when analysts adjusted the next-year EPS growth estimate from 755.71% to 2366.39%.
What sector and industry does Agilon Health Inc belong to?▾
Agilon Health Inc operates in the Healthcare sector, specifically the Medical Care Facilities industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. AGL appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Agilon Health Inc (AGL) appears here because it was detected by our daily top-EPS-revision-performer screen.